Gabriela Alexe
ScholarGPS® ID: 21872628345154
Affiliation History
Field
Medicine
Discipline
Pediatrics
Top Specialties
Cancer | Leukemia | Acute Myeloid Leukemia | Breast Cancer | Myeloid Leukemia | Cancer Cell | Ewing's Sarcoma | Sarcoma | Gene Expression | Acute Lymphoblastic Leukemia
Metrics Summary
Publication Count
98
Predicted Citations
6,222
Predicted h-index
43
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
The KAT module of the SAGA complex maintains the oncogenic gene expression program in MYCN- amplified neuroblastoma (journal article) Science Advances, volume 10, issue 22 (2024). |
The UBE2J2/UBE2K-MARCH5 ubiquitination machinery regulates apoptosis in response to venetoclax in acute myeloid leukemia (journal article) Leukemia, volume 38, issue 3, pages 652-656 (2024). |
Blood Advances, volume 7, issue 21, pages 6685-6701 (2023). |
Blood, volume 142, issue Supplement 1, pages 4174-4174 (2023). |
Combining Menin and MEK Inhibition to Target Poor Prognostic KMT2A -Rearranged RAS Pathway-Mutant Acute Leukemia (journal article) Blood, volume 142, issue Supplement 1, pages 166-166 (2023). |
The UBE2J2/UBE2K-MARCH5 Ubiquitination Machinery Regulates Apoptosis in Response to Venetoclax in Acute Myeloid Leukemia (journal article) Blood, volume 142, issue Supplement 1, pages 2785-2785 (2023). |
Functional Dissection of Cellular Programs to Uncover Novel Gene Dependencies in AML (journal article) Blood, volume 142, issue Supplement 1, pages 1393-1393 (2023). |
Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors (journal article) Cancer Research, volume 83, issue 2, pages 285-300 (2023). |
P410: COMBINING MENIN AND MEK INHIBITION TO TREAT CHILDREN WITH POOR PROGNOSTIC KMT2A-R RAS-MUTANT ACUTE LEUKEMIA (journal article) HemaSphere, volume 7, issue S3, pages e0491723- (2023). |
DHODH: A Promising New Therapeutic Target in Pediatric T-ALL (journal article) Blood, volume 140, issue Supplement 1, pages 7795-7797 (2022). |
Breaking the Pump: Targeting the Sodium-Potassium Pump As a Therapeutic Strategy in Acute Myeloid Leukemia (journal article) Blood, volume 140, issue Supplement 1, pages 4936-4937 (2022). |
Mechanisms of the CBFA2T3-GLIS2 Fusion in AML Maintenance (journal article) Blood, volume 140, issue Supplement 1, pages 5864-5865 (2022). |
Molecular Cancer Research, volume 20, issue 7, pages 1035-1046 (2022). |
Breaking the pump: targeting the sodium-potassium pump as a therapeutic strategy in acute myeloid leukemia (conference) 34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung (2022) Wilsede |
Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy (journal article) Leukemia, volume 36, issue 2, pages 348-360 (2022). |
P455: BREAKING THE PUMP: TARGETING THE SODIUM-POTASSIUM PUMP AS A THERAPEUTIC STRATEGY IN ACUTE MYELOID LEUKEMIA (journal article) HemaSphere, volume 6 (2022). |
Blood, volume 138, issue Supplement 1, pages 3319-3319 (2021). |
Unleashing Cell-Intrinsic Inflammation As a Strategy to Kill AML Blasts (journal article) Blood, volume 138, issue Supplement 1, pages 3305-3305 (2021). |
Cancer Cell, volume 39, issue 9, pages 1262-1278.e7 (2021). |
Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia (journal article) Cancer Discovery, volume 10, issue 2, pages 214-231 (2020). |